Rallybio to Effect 1 for 8 Reverse Stock Split to Regain Nasdaq Compliance
ByAinvest
Wednesday, Feb 4, 2026 11:18 am ET1min read
RLYB--
Rallybio to implement 1 for 8 reverse stock split to regain Nasdaq compliance. The move aims to meet the minimum price requirement for continued listing on Nasdaq and support future business needs. The company received a Nasdaq warning in February 2025 after its stock traded below $1.00 for 30 consecutive business days. No fractional shares will be issued in connection with the reverse split, and stockholders will receive a cash payment in lieu of fractional shares. Rallybio's pipeline candidates address medical needs in complement dysregulation and haematology.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet